195 related articles for article (PubMed ID: 35546670)
1. Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer.
Eberst G; Vernerey D; Laheurte C; Meurisse A; Kaulek V; Cuche L; Jacoulet P; Almotlak H; Lahourcade J; Gainet-Brun M; Fabre E; Le Pimpec-Barthes F; Adotevi O; Westeel V
BMC Cancer; 2022 May; 22(1):529. PubMed ID: 35546670
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.
Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y
Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728
[TBL] [Abstract][Full Text] [Related]
3. CD4 lymphopenia to identify end-of-life metastatic cancer patients.
Péron J; Cropet C; Tredan O; Bachelot T; Ray-Coquard I; Clapisson G; Chabaud S; Philip I; Borg C; Cassier P; Labidi Galy I; Sebban C; Perol D; Biron P; Caux C; Menetrier-Caux C; Blay JY
Eur J Cancer; 2013 Mar; 49(5):1080-9. PubMed ID: 23246297
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
[TBL] [Abstract][Full Text] [Related]
5. [Expression and prognostic value of memory T lymphocyte in patients with non-small cell lung cancer following radiotherapy].
Hu J; Zheng L; Zhang H; Zhang S; Xu G
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):523-528. PubMed ID: 29488720
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients.
Giatromanolaki A; Anestopoulos I; Panayiotidis MI; Mitrakas A; Pappa A; Koukourakis MI
Anticancer Res; 2021 Aug; 41(8):3989-3995. PubMed ID: 34281863
[TBL] [Abstract][Full Text] [Related]
7. CD8
Duchemann B; Naigeon M; Auclin E; Ferrara R; Cassard L; Jouniaux JM; Boselli L; Grivel J; Desnoyer A; Danlos FX; Mezquita L; Caramella C; Marabelle A; Besse B; Chaput N
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35131864
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.
Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551
[TBL] [Abstract][Full Text] [Related]
9. [Effect of CD4-positive T lymphocyte expression rate on pain control and prognosis in stage Ⅳ non-small cell lung cancer patients with cancerous pain].
Chen H; Guo DP; Liu C; Wu GH; Li YW; Fan BF; Xie GL
Zhonghua Yi Xue Za Zhi; 2022 Oct; 102(39):3110-3114. PubMed ID: 36274594
[No Abstract] [Full Text] [Related]
10. Long-term prognostic significance of interleukin-17-producing T cells in patients with non-small cell lung cancer.
Song L; Ma S; Chen L; Miao L; Tao M; Liu H
Cancer Sci; 2019 Jul; 110(7):2100-2109. PubMed ID: 31100180
[TBL] [Abstract][Full Text] [Related]
11. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Ablative Radiation Therapy for Pulmonary Recurrence-Based Oligometastatic Non-Small Cell Lung Cancer: Survival and Prognostic Value of Regulatory T Cells.
Liu C; Sun B; Hu X; Zhang Y; Wang Q; Yue J; Yu J
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1055-1064. PubMed ID: 31437470
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
[No Abstract] [Full Text] [Related]
14. Long-term survival analysis of patients with stage IIIB-IV non-small cell lung cancer complicated by type 2 diabetes mellitus: A retrospective propensity score matching analysis.
Li X; Fang H; Zhang D; Xia L; Wang X; Yang J; Zhang S; Su Y; Zhu Y
Thorac Cancer; 2022 Dec; 13(23):3268-3273. PubMed ID: 36217741
[TBL] [Abstract][Full Text] [Related]
15. The associations of CD4 count, CD4/CD8 ratio, and HIV viral load with survival from non-small cell lung cancer in persons living with HIV.
Klugman M; Fazzari M; Xue X; Ginsberg M; Rohan TE; Halmos B; Hanna DB; Shuter J; Hosgood HD
AIDS Care; 2022 Aug; 34(8):1014-1021. PubMed ID: 34074183
[TBL] [Abstract][Full Text] [Related]
16. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Iversen TZ
Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
[TBL] [Abstract][Full Text] [Related]
17. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
Yan Y; Wang X; Liu C; Jia J
BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
[TBL] [Abstract][Full Text] [Related]
18. Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor.
Inomata M; Kado T; Okazawa S; Imanishi S; Taka C; Kambara K; Hirai T; Tanaka H; Tokui K; Hayashi K; Miwa T; Hayashi R; Matsui S; Tobe K
Anticancer Res; 2019 Dec; 39(12):6887-6893. PubMed ID: 31810958
[TBL] [Abstract][Full Text] [Related]
19. Smoking history influences the prognostic value of peripheral naïve CD4+ T cells in advanced non-small cell lung cancer.
Liu C; Xu B; Li Q; Li A; Li L; Yue J; Hu Q; Yu J
Cancer Cell Int; 2019; 19():176. PubMed ID: 31320838
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
Front Immunol; 2022; 13():835630. PubMed ID: 35401554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
